2016-2017 MGH Pathology Grand Rounds

Thursdays, 12:00-1:00 pm, O'Keefe Auditorium, MGH Blake 1 (unless otherwise noted)

NameDate of talkTitle of talk -or- subject to be discussed
Chin-Lee Wu, M.D.
Associate Professor of Pathology
Harvard Medical School
Associate Pathologist
Director, Urologic Pathology
Massachusetts General Hospital
9/29/2016 “The Role of Pathologist in the Diagnosis and Management of Prostate Cancer: from Morphology and Beyond”
Frederick A. Meier, M.D.
Henry Ford Hospital
Detroit, Michigan
10/20/2016 “Pathology in Mbarara, Uganda: fascinating and challenging”
Marc Ladanyi, M.D.
The William Ruane Chair in Molecular Oncology Attending Pathologist and Chief
Molecular Diagnostic Service Member
Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
10/27/2016 “MSK-IMPACT initiative in prospective clinical cancer genomics: the first 10,000 patients”
Jason Hornick, M.D.
Associate Professor of Pathology
Director of Surgical Pathology
Director, Immunohistochemistry Laboratory
Brigham and Women’s Hospital
11/17/2016 “The Evolution of Immunohistochemistry for Soft Tissue Tumors: From Differentiation to Molecular Genetics”
David N. Louis, M.D.
Massachusetts General Hospital
Benjamin Castleman Professor of Pathology, Harvard Medical School
12/8/2016 “10 year presentation as Chief of Pathology”
Risk Management – Dr. Ross Reichard
Professor of Pathology
Mayo Clinic
12/15/2016 "Risk Management Quality Assurance Topic”
Heidi Rehm, PhD, FACMG
Associate Professor, Pathology
Director, Partners Laboratory for Molecular Medicine
1/12/2017 TBA
Vania Nosé, MD, PhD
Associate Chief of Anatomic and Molecular Pathology, Professor of Pathology, Harvard Medical School
William C. Faquin, MD, PhD
Director, Head & Neck Pathology
Associate Professor, Harvard Medical School
Peter M. Sadow, MD, PhD
Director, Head & Neck Pathology, Massachusetts General Hospital, Assistant Professor of Pathology, Harvard Medical School
1/19/2017 “NIFTP”
Gaddy Getz, M.D.
Associate Professor Pathology
Department of Pathology
Director, Cancer Genome Computational Analysis Group
Massachusetts General Hospital
1/26/2017 TBA
Richard Max Kaufman, M.D.
Medical Director, Brigham & Women’s Hospital Adult Transfusion Service
Associate Professor, Harvard Medical School
2/9/2017 “Truth or Daratumumab? New Drug, New Blood Bank Conundrum”
Risk Management – CRICO 2/16/2017 “Strategies to Minimize Risk and Improve Patient Safety”
Combined Grand Rounds –
Dr. Benjamin Ebert
3/16/2017 “Combined MGH Cancer Center Rounds/Pathology Grand Rounds”
Guillermo Tearney, M.D.
Mike and Sue Hazard Family MGH Research Scholar
Professor of Pathology, Harvard Medical School
Wellman Center for Photomedicine
Massachusetts General Hospital
3/30/2017 TBA
Mari Mino-Kenudson, MD
Associate Pathologist, MGH
Medical Director, Frozen Section Laboratory
Director, Pulmonary Pathology Service
Associate Professor, HMS
4/20/2017 “Paradigm shift in lung cancer treatment and a role of the pathologist – from platinum doublet to immunotherapy”

Raj Gapol, M.D.
Assistant in Medicine, HMS
Instructor in Medicine, MGH
4/27/2017 “Genomic Analysis of Mitochondria-Rich Tumors”
Charles Parkos, M.D.
Carl V. Weller Professor and Chair,
Mucosal Inflammation and Epithelial Pathobiology
Department of Pathology
University of Michigan School of Medicine
5/18/17 “The yin and yang of leukocyte-epithelial interactions”
Alex Lazar, M.D.
Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine
The University of Texas MD Anderson Center, Houston, TX



Risk Management 6/15/17 “Risk Management Discussion”

Back to Top